First human tests begin for new antibiotic candidate
NCT ID NCT04314206
Summary
This early-stage study aimed to check the safety and see how the body absorbs and processes an experimental drug called VNRX-5024. It involved 36 healthy adult volunteers who took either the drug or a placebo for up to 10 days. The main goal was to find a safe dose range and understand how the drug moves through the body before testing it in sick patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PRA Health Sciences - Early Development Services
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.